Vuong V - Search Results

1

Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation.

Gupta A, Probst HC, Vuong V, Landshammer A, Muth S, Yagita H, Schwendener R, Pruschy M, Knuth A, van den Broek M. Gupta A, et al. Among authors: vuong v. J Immunol. 2012 Jul 15;189(2):558-66. doi: 10.4049/jimmunol.1200563. Epub 2012 Jun 8. J Immunol. 2012. PMID: 22685313

2

Novel radiosensitizers for locally advanced epithelial tumors: inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy?

Riesterer O, Tenzer A, Zingg D, Hofstetter B, Vuong V, Pruschy M, Bodis S. Riesterer O, et al. Among authors: vuong v. Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):361-8. doi: 10.1016/j.ijrobp.2003.09.050. Int J Radiat Oncol Biol Phys. 2004. PMID: 14751504

3

Current concepts for the combined treatment modality of ionizing radiation with anticancer agents.

Oehler C, Dickinson DJ, Broggini-Tenzer A, Hofstetter B, Hollenstein A, Riesterer O, Vuong V, Pruschy M. Oehler C, et al. Among authors: vuong v. Curr Pharm Des. 2007;13(5):519-35. doi: 10.2174/138161207780162935. Curr Pharm Des. 2007. PMID: 17348847 Review.

4

Metabolism of tumors under treatment: mapping of metabolites with quantitative bioluminescence.

Broggini-Tenzer A, Vuong V, Pruschy M. Broggini-Tenzer A, et al. Among authors: vuong v. Radiother Oncol. 2011 Jun;99(3):398-403. doi: 10.1016/j.radonc.2011.05.041. Epub 2011 Jun 12. Radiother Oncol. 2011. PMID: 21665309

5

Dynamics of tumor hypoxia in response to patupilone and ionizing radiation.

Orlowski K, Rohrer Bley C, Zimmermann M, Vuong V, Hug D, Soltermann A, Broggini-Tenzer A, Pruschy M. Orlowski K, et al. Among authors: vuong v. PLoS One. 2012;7(12):e51476. doi: 10.1371/journal.pone.0051476. Epub 2012 Dec 10. PLoS One. 2012. PMID: 23251549 Free PMC article.

6

Role of the microenvironment for radiosensitization by patupilone.

Bley CR, Jochum W, Orlowski K, Furmanova P, Vuong V, McSheehy PM, Pruschy M. Bley CR, et al. Among authors: vuong v. Clin Cancer Res. 2009 Feb 15;15(4):1335-42. doi: 10.1158/1078-0432.CCR-08-0969. Clin Cancer Res. 2009. PMID: 19228735 Free article.

7

Signal transduction inhibitors as radiosensitizers.

Tenzer A, Zingg D, Riesterer O, Vuong V, Bodis S, Pruschy M. Tenzer A, et al. Among authors: vuong v. Curr Med Chem Anticancer Agents. 2002 Nov;2(6):727-42. doi: 10.2174/1568011023353651. Curr Med Chem Anticancer Agents. 2002. PMID: 12678723 Review.

8

The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models.

Sharma A, Broggini-Tenzer A, Vuong V, Messikommer A, Nytko KJ, Guckenberger M, Bachmann F, Lane HA, Pruschy M. Sharma A, et al. Among authors: vuong v. Radiother Oncol. 2017 Sep;124(3):433-438. doi: 10.1016/j.radonc.2017.07.024. Epub 2017 Aug 7. Radiother Oncol. 2017. PMID: 28797699

9

Patupilone acts as radiosensitizing agent in multidrug-resistant cancer cells in vitro and in vivo.

Hofstetter B, Vuong V, Broggini-Tenzer A, Bodis S, Ciernik IF, Fabbro D, Wartmann M, Folkers G, Pruschy M. Hofstetter B, et al. Among authors: vuong v. Clin Cancer Res. 2005 Feb 15;11(4):1588-96. doi: 10.1158/1078-0432.CCR-04-1800. Clin Cancer Res. 2005. PMID: 15746064

10

Hypoxia modulation and radiosensitization by the novel dual EGFR and VEGFR inhibitor AEE788 in spontaneous and related allograft tumor models.

Oehler-Jänne C, Jochum W, Riesterer O, Broggini-Tenzer A, Caravatti G, Vuong V, Pruschy M. Oehler-Jänne C, et al. Among authors: vuong v. Mol Cancer Ther. 2007 Sep;6(9):2496-504. doi: 10.1158/1535-7163.MCT-07-0253. Mol Cancer Ther. 2007. PMID: 17876047 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters